RxDoctor Payments Data

Nabila Al-Barghouthy

Physician Assistant · Thornwood, NYNPI 1730126889

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $23,377 of the $36,919 with a category attached, or 63.3%. 42 manufacturers reported payments, led by AbbVie at 36.9% of the total. 2025 is the largest year on record at $13,304, 6.7 times the $1,979 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,919in general payments, 2019–2025

Across 837 payments — averaging $44.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$10K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Amneal Pharmaceuticals LLC$1K
  • Lilly USA, LLC$1K
  • Vanda Pharmaceuticals Inc.$876
  • plus $9K from 36 others

What the payments were for

  • Consulting fees$3,87510%
  • Speaking & faculty fees$8,59023%
  • Travel & lodging$9433%
  • Food & beverage$23,37763%
  • Education$1340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,919 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant68$92,712
VraylarCariprazine Hcl53$73,610
QuliptaAtogepant41$42,914
RexultiBrexpiprazole20$34,618
CaplytaLumateperone Tosylate12$25,004
Nurtec OdtRimegepant Sulfate12$20,734
NamzaricMemantine Hcl/Donepezil Hcl24$16,691
AuvelityDextromethorphan Hbr/Bupropion14$12,668
Aimovig AutoinjectorErenumab-Aooe12$8,452
Doxepin Hcl16$8,055
Vilazodone Hcl14$2,555
Rivastigmine12$1,489
Sertraline Hcl33$1,035
Aripiprazole44$991
Mirtazapine61$776

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Vraylar, Qulipta, Namzaric$13,633$225,926186 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,223$34,61820 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$10,218$25,00412 claims
PfizerNurtec Odt$649$20,73412 claims
Axsome Therapeutics, Inc.Auvelity$826$12,66814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Thornwood

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →